Dr. Moore on the Role of Mirvetuximab Soravtansine in Ovarian Cancer

Integrating New Research Information into Current Clinical Care — Ovarian CancerПодробнее

Dr. Moore on Safety Profile of Mirvetuximab Soravtansine in Ovarian CancerПодробнее

Dr. Moore on Anticipated Impact of the MIRASOL Trial in Platinum-Resistant Ovarian CancerПодробнее

Dr. Moore on Early-Phase Data With Mirvetuximab Soravtansine in Ovarian CancerПодробнее

An Overview of a Study Exploring Mirvetuximab Soravtansine in Ovarian CancerПодробнее

Dr. Moore on Benefit of Mirvetuximab Soravtansine in Patients With Ovarian CancerПодробнее